# Barricaid EU Post Market Study for Primary Lumbar Disc Herniation

> **NCT01534065** · NA · COMPLETED · sponsor: **Intrinsic Therapeutics** · enrollment: 45 (actual)

## Conditions studied

- Lumbar Disc Herniation

## Interventions

- **DEVICE:** Barricaid

## Key facts

- **NCT ID:** NCT01534065
- **Lead sponsor:** Intrinsic Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01534065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01534065, "Barricaid EU Post Market Study for Primary Lumbar Disc Herniation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01534065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*